nuclear-medicine-radiation-therapy-2018-tracks

Page 36

Journal of Medical Physics and Applied Sciences

ISSN: 2574-285X

I n t e r n a t i o n a l C o n f e r e n c e o n

Nuclear Medicine &

Radiation Therapy

Nuclear Medicine & Radiation Therapy 2018

O c t o b e r 0 1 - 0 2 , 2 0 1 8

S t o c k h o l m , S w e d e n

Nuclear medicine imaging – Effective cost saving of radio tracers

O Evbuomwan, K Purbhoo and MDTH Vangu

University of the Witwatersrand, South Africa

Biography

Dr Evbuomwan has completed hismasters inmedicine (MMED,

Nuclear medicine) from the University of the Witwatersrand,

Johannesburg, South Africa. He is currently a nuclear medi-

cine specialist practicing in Charlotte Maxeke Johannesburg

Academic Hospital. He has published lots of papers in reputed

journals. He is also a presenter in both local and international

conferences and a reviewer for high impact journals.

There are FDA approved radiopharmaceuticals for various nuclear medicine

imaging procedures. Examples will include 99mTc DTPA as a radioaerosol for

ventilation studies and 99mTc sulphur colloid for milk scans. We now live in the era

of health economics and it has become essential for resource constraint facilities

to developmeans to save cost whilemaintaining acceptable standards. The use of

one radiopharmaceutical for different nuclear medicine studies for example may

offer opportunities to do so.

Aim:

To show how radiopharmaceuticals may be used cost-effectively in a busy

nuclear medicine practice.

Methods:

We looked at two studies that have been conducted in our facility over

the last 2 years. One was a randomized prospective study where 99mTc MDP and

MIBI were compared with 99mTc DTPA for lung ventilation scintigraphy in patients

with suspected pulmonary embolism. The second study was a retrospective

study were 99mTc nanocolloid was used in place of 99mTc sulphur colloid for

performing milk scans.

Results and Conclusion:

The alternative agents in both studies were shown to be

cost saving to the department with good quality images. 99mTc MIBI was also

shown to be a better radioaerosol for ventilation when compared to 99mTcDTPA.

Spare doses drawn up from a vial being used for myocardial perfusion imaging

can be used for ventilation scintigraphy. Spare doses of 99mTc nanocolloid drawn

up from a vial being used for lymphoscintigraphy, sentinel lymph node mapping or

bone marrow imaging can be used for performing milk scans.

O Evbuomwan et al., J. med phys & appl sci 2018, Volume: 3

DOI: 10.21767/2574-285X-C1-002